# A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy.

> PubMed lists PMID 32096613 in Journal of cachexia, sarcopenia and muscle as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-02-25 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32096613-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-08-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32096613-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32096613-elamipretide-v1.json
- Content SHA-256: `d3b079723729f320ba4a798833e041467fe5d5c5fe258349d7d793ac7f665fa3`

## Claims and source pins

### Headline

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. ([`pubmed-observation-pmid-32096613-2024-08-01-2de27befa715`](#source-pubmed-observation-pmid-32096613-2024-08-01-2de27befa715))

### Summary

PubMed lists PMID 32096613 in Journal of cachexia, sarcopenia and muscle as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-02-25 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32096613-2024-08-01-2de27befa715`](#source-pubmed-observation-pmid-32096613-2024-08-01-2de27befa715))

### Paragraph 1

PubMed lists PMID 32096613 in Journal of cachexia, sarcopenia and muscle as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-02-25 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32096613-2024-08-01-2de27befa715`](#source-pubmed-observation-pmid-32096613-2024-08-01-2de27befa715))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32096613-2024-08-01-2de27befa715`](#source-pubmed-observation-pmid-32096613-2024-08-01-2de27befa715))

## Sources

<a id="source-pubmed-observation-pmid-32096613-2024-08-01-2de27befa715"></a>
- **A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. · retained source version 1:2024-08-01:current:2de27befa715b62f9d131c1f5e2925f1252d023bb34e809baa79a7b2c7acb59b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32096613/) (`pubmed-observation-pmid-32096613-2024-08-01-2de27befa715`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32096613-elamipretide-v1.json SHA-256: d3b079723729f320ba4a798833e041467fe5d5c5fe258349d7d793ac7f665fa3.